Publications by authors named "Michael Carden"

Claim this Profile
R
Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention.
Benjamin Eckhardt, Emily R Winkelstein, Marla A Shu, Michael R Carden, Courtney McKnight

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Hepatitis C in Users of Illicit Drugs.
Brian R Edlin, Michael R Carden, Stephen J Ferrando

Curr Hepat Rep· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
Jason Cota, Michael Carden, John R Graybill, Laura K Najvar, David S Burgess

Antimicrob Agents Chemother· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injection drug users: the overlooked core of the hepatitis C epidemic.
Brian R Edlin, Michael R Carden

Clin Infect Dis· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Written in response to Scott LD: treating hepatitis C in active injection drug users.
Brian R Edlin, Michael R Carden

Am J Gastroenterol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
Brian R Edlin, Thomas F Kresina, Daniel B Raymond, Michael R Carden, Marc N Gourevitch

Clin Infect Dis· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis